Last update:

Medications news

Medications

Clinical trial highlights promising new treatment for intestinal worms

A new tablet combining albendazole and ivermectin is safe and more effective than albendazole alone in treating Trichuris trichiura and other soil-transmitted helminths (STH), according to a clinical trial conducted by the ...

Medications

Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs

A new study examining the use of high-cost drugs among patients with colorectal cancer and non-small cell lung cancer found those insured through Medicare Advantage received less expensive cancer drugs compared to others ...

Medications

Medicare rules may reduce prescription steering

Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to medicines for most patients in the United States—steer patients to use their own pharmacies. However, ...

Medications

New drug for prostate cancer patients in clinical trials

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in the journal Clinical ...

Medications

Talquetamab plus teclistamab shows promise in multiple myeloma

For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high percentage of patients and a higher incidence of grade 3 or 4 infections than with either therapy alone, according ...

Medications

DoxyPEP use linked to sharp decline in STI cases

A new study has found that rates of chlamydia and syphilis plummet among people prescribed doxycycline for sexually transmitted infection prevention in routine clinical care.

Medications

How legal pot may be reducing opioid prescriptions

In states where medical marijuana is legal, payments from opioid manufacturers to physicians have decreased significantly—suggesting that marijuana may be emerging as a viable alternative to opioids for pain management, ...

Medications

EU watchdog puts sickle cell disease drug on ice

The EU's drug watchdog Thursday called for the suspension of approval for Pfizer's medicine to treat sickle cell disease, saying doctors should stop using the drug.

Medications

FDA approves Bimzelx for three new indications

The U.S. Food and Drug Administration has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with active psoriatic arthritis (PsA), adults with active nonradiographic axial spondyloarthritis (nr-axSpA) with objective ...

Medications

US Congress calls on Novo Nordisk to lower drug prices

The boss of the Danish pharmaceutical giant behind the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy promised Tuesday to examine lowering their prices in the United States, after coming under pressure from ...

Medications

New migraine drugs no better than cheap painkillers: big study

New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and even performed worse than an older range of treatments called triptans, said a massive global analysis ...

Medications

The winding, fitful path to diabetes drug Ozempic

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic—so what was that journey like for the scientists involved?

Medications

Weight loss drugs could help fight fatty liver disease

In the fight against fatty liver disease, researchers are looking for any and all possible solutions. But to combat the disease, which is also known as metabolic dysfunction-associated steatotic liver disease, or MASLD, scientists ...